- Home
- FSBC vs AUTL Comparison
FSBC vs AUTL Comparison
Compare FSBC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- AUTL
- Stock Information
- Founded
- FSBC 2002
- AUTL 2014
- Country
- FSBC United States
- AUTL United Kingdom
- Employees
- FSBC N/A
- AUTL N/A
- Industry
- FSBC Banks
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSBC Finance
- AUTL Health Care
- Exchange
- FSBC Nasdaq
- AUTL Nasdaq
- Market Cap
- FSBC 639.8M
- AUTL 609.4M
- IPO Year
- FSBC 2021
- AUTL 2018
- Fundamental
- Price
- FSBC $29.65
- AUTL $2.21
- Analyst Decision
- FSBC Buy
- AUTL Strong Buy
- Analyst Count
- FSBC 3
- AUTL 3
- Target Price
- FSBC $34.67
- AUTL $10.20
- AVG Volume (30 Days)
- FSBC 43.2K
- AUTL 1.7M
- Earning Date
- FSBC 01-27-2025
- AUTL 11-12-2024
- Dividend Yield
- FSBC 2.73%
- AUTL N/A
- EPS Growth
- FSBC N/A
- AUTL N/A
- EPS
- FSBC 2.25
- AUTL N/A
- Revenue
- FSBC $113,173,000.00
- AUTL $10,091,000.00
- Revenue This Year
- FSBC N/A
- AUTL $851.83
- Revenue Next Year
- FSBC $20.37
- AUTL $264.18
- P/E Ratio
- FSBC $13.01
- AUTL N/A
- Revenue Growth
- FSBC N/A
- AUTL 82.71
- 52 Week Low
- FSBC $21.10
- AUTL $2.07
- 52 Week High
- FSBC $35.13
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- FSBC 41.47
- AUTL 35.87
- Support Level
- FSBC $28.05
- AUTL $2.17
- Resistance Level
- FSBC $30.05
- AUTL $2.80
- Average True Range (ATR)
- FSBC 0.80
- AUTL 0.17
- MACD
- FSBC -0.10
- AUTL 0.02
- Stochastic Oscillator
- FSBC 46.51
- AUTL 19.18
About FSBC Five Star Bancorp
Five Star Bancorp is a California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.